Literature DB >> 25769941

Effects of chronic doxepin and amitriptyline administration in naïve mice and in neuropathic pain mice model.

J Mika1, A M Jurga2, J Starnowska2, M Wasylewski2, E Rojewska2, W Makuch2, K Kwiatkowski2, N Malek2, B Przewlocka3.   

Abstract

Neuropathic pain is a severe clinical problem, often appearing as a co-symptom of many diseases or manifesting as a result of damage to the nervous system. Many drugs and agents are currently used for the treatment of neuropathic pain, such as tricyclic antidepressants (TCAs). The aims of this paper were to test the effects of two classic TCAs, doxepin and amitriptyline, in naïve animals and in a model of neuropathic pain and to determine the role of cytokine activation in the effects of these drugs. All experiments were carried out with Albino-Swiss mice using behavioral tests (von Frey test and the cold plate test) and biochemical analyses (qRT-PCR and Western blot). In the mice subjected to chronic constriction injury (CCI), doxepin and amitriptyline attenuated the symptoms of neuropathic pain and diminished the CCI-induced increase in the levels of spinal interleukin (IL)-6 and -1β mRNA, but not the protein levels of these cytokines, measured on day 12. Unexpectedly, chronic administration of doxepin or amitriptyline for 12 days produced allodynia and hyperalgesia in naïve mice. The treatment with these drugs did not influence the spinal levels of IL-1β and IL-6 mRNA, however, the protein levels of these pronociceptive factors were increased. The administration of ondansetron (5-HT3 receptor antagonist) significantly weakened the allodynia and hyperalgesia induced by both antidepressants in naïve mice; in contrast, yohimbine (α2-adrenergic receptors antagonist) did not influence these effects. Allodynia and hyperalgesia induced in naïve animals by amitriptyline and doxepin may be associated with an increase in the levels of pronociceptive cytokines resulting from 5-HT3-induced hypersensitivity. Our results provide new and important information about the possible side effects of antidepressants. Further investigation of these mechanisms may help to guide decisions about the use of classic TCAs for therapy.
Copyright © 2015 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  antidepressants; interleukin-1β; interleukin-6; ondansetron; pain; yohimbine

Mesh:

Substances:

Year:  2015        PMID: 25769941     DOI: 10.1016/j.neuroscience.2015.03.003

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  7 in total

1.  Effect of photobiomodulation therapy (808 nm) in the control of neuropathic pain in mice.

Authors:  Ana Laura Martins de Andrade; Paulo Sérgio Bossini; Azair Liane Matos do Canto De Souza; Ariane Dutra Sanchez; Nivaldo Antonio Parizotto
Journal:  Lasers Med Sci       Date:  2017-03-10       Impact factor: 3.161

2.  Clipping Hind Paws Under Isoflurane Sedation as a Useful Tool for Evaluation of Chronic Pain in CCI Animals.

Authors:  Young-Chang Arai; Reiko Nobuhara; Shuichi Aono; Keiko Owari; Hironori Saisu; Akihiro Ito; Yoshikazu Sakakima; Masafumi Nakagawa; Kouhei Yamakawa; Makoto Nishihara; Tatsunori Ikemoto; Takahiro Ushida
Journal:  Anesth Pain Med       Date:  2020-04-07

3.  Toxoplasma gondii Infection Promotes Neuroinflammation Through Cytokine Networks and Induced Hyperalgesia in BALB/c Mice.

Authors:  Hossein Mahmoudvand; Naser Ziaali; Hamed Ghazvini; Saeideh Shojaee; Hossein Keshavarz; Khadijeh Esmaeilpour; Vahid Sheibani
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

4.  Analgesia induced by the epigenetic drug, L-acetylcarnitine, outlasts the end of treatment in mouse models of chronic inflammatory and neuropathic pain.

Authors:  Serena Notartomaso; Giada Mascio; Matteo Bernabucci; Cristina Zappulla; Pamela Scarselli; Milena Cannella; Tiziana Imbriglio; Roberto Gradini; Giuseppe Battaglia; Valeria Bruno; Ferdinando Nicoletti
Journal:  Mol Pain       Date:  2017-01       Impact factor: 3.395

5.  Neuropathic Pain Dysregulates Gene Expression of the Forebrain Opioid and Dopamine Systems.

Authors:  Agnieszka Wawrzczak-Bargieła; Barbara Ziółkowska; Anna Piotrowska; Joanna Starnowska-Sokół; Ewelina Rojewska; Joanna Mika; Barbara Przewłocka; Ryszard Przewłocki
Journal:  Neurotox Res       Date:  2020-02-05       Impact factor: 3.911

6.  Analysis of the effects of a tricyclic antidepressant on secondary sleep disturbance induced by chronic pain in a preclinical model.

Authors:  Hisakatsu Ito; Yoshinori Takemura; Yuta Aoki; Mizuki Hattori; Hideyo Horikawa; Mitsuaki Yamazaki
Journal:  PLoS One       Date:  2020-12-03       Impact factor: 3.240

7.  Doxepin prevents the Expression and Development of Paclitaxel-Induced Neuropathic Pain.

Authors:  Hajar Naji Esfahani; Golnaz Vaseghi; Shaghayegh Haghjooy Javanmard; Aliasghar Pilehvarian
Journal:  Adv Biomed Res       Date:  2021-11-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.